The vaccine is recommended to be administered once in a dose of 0.5 ml. The vaccine is intended for deep intramuscular administration:
Intravenous administration is categorically contraindicated. After vaccination, it is recommended:
Before vaccination, it is recommended to examine the child and exclude contact with SARS patients.
Patients should be under medical supervision for 30 minutes after administration of the vaccine.
The combined vaccine for the prevention of diphtheria, tetanus, and pertussis is used in children aged 2 months and older.
Hypersensitivity to any component of the vaccine, severe complications that occurred after previous doses of this vaccine, children suffering from epilepsy and encephalopathy.
After vaccination can be observed:
In the presence of mechanical inclusions or a solution with a strange color, the use of the vaccine is unacceptable.